Wolf Dataware

Taiwan D0201a

Health & Biotech

Looking for

Wolf Dataware platform is a cell and gene therapy platform embedded with no-code development, AI and blockchain technologies. Because of the new regulation published by Taiwan government to legalize autologous cell therapy, we estimate 600 GTP labs will be established in 3 to 5 years. Currently, Wolf Dataware is the only company providing the cell therapy platform in Taiwan and we are helping every labs and hospitals to solve the complicated supply chain and logistics issues in cell therapy. While helping our clients to solve the problem, we collect comprehensive data, then we can use the data to build models of gold standard treatment for individual patients.

[{"bannerId":"48dec9a1-3e73-4255-88e6-95d14d2c27b9","imgPathWide":"/2020/_uploads/202101040952071641.jpg","imgPathThin":null,"go2Url":"https://innovex.computex.biz/2020/SHOW/pressReleaseDetails.aspx?newsId=313","ifOpenNew":true,"landAt":"2020Show","seq":1,"title":null}]